IXC vs NSB

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

IXC

INVEX THER FPO [IXC]

48LOW

NSB

NEUROSCIEN FPO [NSB]

49LOW

Score Breakdown

IXC NSB
Technical
59
51
Catalyst
50
50
Sentiment
50
50
Fundamental
57
79
Momentum
50
36
Risk Gate
40
46

Key Metrics

IXC Metric NSB
$7.9MMarket Cap$23.8M
47KAvg Volume (20d)248K
N/AShort InterestN/A
$0.18052-Week High$0.260
$0.07552-Week Low$0.055
+9.5%Daily Change+0.0%
$0.115Reference Price$0.061
-16.8%ROE-29.6%
N/AProfit MarginN/A

Active Signals

IXC Signals

●MACD momentum is picking up steam
●Volume surging at 24.2x normal while price falls — heavy selling pressure
●Knocking on the door of resistance — if it punches through, things could get interesting
●On a tear — up 15.0% over the last 5 days
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (41 quarters)
●4C filed 2026-04-24

NSB Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 6.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)
●Very high P/S ratio (74.8x)
●Strong revenue growth (+129%)

Ask Scout AI to compare IXC and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IXC vs VIT →LDX vs MVP →LDX vs NAN →LDX vs NTI →LDX vs NYR →
IXC Full Analysis → NSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).